Larry Altstiel Named vTv Therapeutics Chief Medical Officer

Alzheimer’s drug developer vTv Therapeutics (NASDAQ: VTVT) has named Larry Altstiel the High Point, NC, company’s chief medical officer. Altstiel’s experience includes research and management roles at Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY). Most recently, Altstiel was CEO of Provectra Biotherapeutics, which is developing a gene therapy for neurogenerative diseases. Last July, vTv completed a $117 million initial public offering to finance late-stage clinical trials for its Alzheimer’s drug candidate.

Frank Vinluan is editor of Xconomy Raleigh-Durham, based in Research Triangle Park. You can reach him at fvinluan [at] xconomy.com Follow @frankvinluan

Trending on Xconomy